Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2929

1.

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.

Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, Bras J, Young E, von Coelln R, Simón-Sánchez J, Schulte C, Sharma M, Krohn L, Pihlstrøm L, Siitonen A, Iwaki H, Leonard H, Faghri F, Gibbs JR, Hernandez DG, Scholz SW, Botia JA, Martinez M, Corvol JC, Lesage S, Jankovic J, Shulman LM, Sutherland M, Tienari P, Majamaa K, Toft M, Andreassen OA, Bangale T, Brice A, Yang J, Gan-Or Z, Gasser T, Heutink P, Shulman JM, Wood NW, Hinds DA, Hardy JA, Morris HR, Gratten J, Visscher PM, Graham RR, Singleton AB; 23andMe Research Team; System Genomics of Parkinson's Disease Consortium; International Parkinson's Disease Genomics Consortium.

Lancet Neurol. 2019 Dec;18(12):1091-1102. doi: 10.1016/S1474-4422(19)30320-5.

PMID:
31701892
2.

Do heterozygous mutations of Niemann-Pick type C predispose to late-onset neurodegeneration: a review of the literature.

Schneider SA, Tahirovic S, Hardy J, Strupp M, Bremova-Ertl T.

J Neurol. 2019 Nov 7. doi: 10.1007/s00415-019-09621-5. [Epub ahead of print] Review.

PMID:
31701332
3.

The Parkinson's Disease Mendelian Randomization Research Portal.

Noyce AJ, Bandres-Ciga S, Kim J, Heilbron K, Kia D, Hemani G, Xue A, Lawlor DA, Smith GD, Duran R, Gan-Or Z, Blauwendraat C, Gibbs JR; 23andMe Research Team5, International Parkinson's Disease Genomics Consortium (IPDGC), Hinds DA, Yang J, Visscher P, Cuzick J, Morris H, Hardy J, Wood NW, Nalls MA, Singleton AB.

Mov Disord. 2019 Oct 28. doi: 10.1002/mds.27873. [Epub ahead of print]

PMID:
31659794
4.

Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease.

Seth A, Orkin S, Yodoshi T, Liu C, Fei L, Hardy J, Trout AT, Arce Clachar AC, Bramlage K, Xanthakos S, Mouzaki M.

Pediatr Obes. 2019 Oct 27. doi: 10.1111/ijpo.12581. [Epub ahead of print]

PMID:
31657145
5.

Low-molecular-mass iron complexes in blood plasma of iron-deficient pigs do not originate directly from nutrient iron.

Dziuba N, Hardy J, Lindahl PA.

Metallomics. 2019 Oct 11. doi: 10.1039/c9mt00152b. [Epub ahead of print]

PMID:
31603444
6.

Informing disease modelling with brain-relevant functional genomic annotations.

Reynolds RH, Hardy J, Ryten M, Gagliano Taliun SA.

Brain. 2019 Oct 11. pii: awz295. doi: 10.1093/brain/awz295. [Epub ahead of print]

PMID:
31603214
7.

Histone deposition promotes recombination-dependent replication at arrested forks.

Hardy J, Dai D, Ait Saada A, Teixeira-Silva A, Dupoiron L, Mojallali F, Fréon K, Ochsenbein F, Hartmann B, Lambert S.

PLoS Genet. 2019 Oct 4;15(10):e1008441. doi: 10.1371/journal.pgen.1008441. eCollection 2019 Oct.

8.

Uptake and Release of Species from Carbohydrate Containing Organogels and Hydrogels.

Pan A, Roy SG, Haldar U, Mahapatra RD, Harper GR, Low WL, De P, Hardy JG.

Gels. 2019 Sep 30;5(4). pii: E43. doi: 10.3390/gels5040043.

9.

Single genome sequencing of near full-length HIV-1 RNA using a limiting dilution approach.

Hebberecht L, Vancoillie L, Schauvliege M, Staelens D, Demecheleer E, Hardy J, Mortier V, Verhofstede C.

J Virol Methods. 2019 Dec;274:113737. doi: 10.1016/j.jviromet.2019.113737. Epub 2019 Sep 25.

10.

The flagellotropic bacteriophage YSD1 targets Salmonella Typhi with a Chi-like protein tail fibre.

Dunstan RA, Pickard D, Dougan S, Goulding D, Cormie C, Hardy J, Li F, Grinter R, Harcourt K, Yu L, Song J, Schreiber F, Choudhary J, Clare S, Coulibaly F, Strugnell RA, Dougan G, Lithgow T.

Mol Microbiol. 2019 Sep 25. doi: 10.1111/mmi.14396. [Epub ahead of print]

PMID:
31556164
11.

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease.

Sjödin S, Brinkmalm G, Öhrfelt A, Parnetti L, Paciotti S, Hansson O, Hardy J, Blennow K, Zetterberg H, Brinkmalm A.

Alzheimers Res Ther. 2019 Sep 14;11(1):82. doi: 10.1186/s13195-019-0533-9.

12.

Progress in the Genetic Analysis of Parkinson's Disease.

Singleton A, Hardy J.

Hum Mol Genet. 2019 Sep 13. pii: ddz183. doi: 10.1093/hmg/ddz183. [Epub ahead of print]

PMID:
31518392
13.

Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial.

Hardy JR, Skerman H, Philip J, Good P, Currow DC, Mitchell G, Yates P.

BMJ Open. 2019 Sep 12;9(9):e029942. doi: 10.1136/bmjopen-2019-029942.

14.

Effect of CFIm68 knockdown on RNA polymerase II transcription.

Tellier M, Hardy JG, Norbury CJ, Murphy S.

BMC Res Notes. 2019 Sep 2;12(1):554. doi: 10.1186/s13104-019-4582-8.

15.

Microvesicle-mediated delivery of minicircle DNA results in effective gene-directed enzyme prodrug cancer therapy.

Kanada M, Kim BD, Hardy JW, Ronald JA, Bachmann MH, Bernard MP, Perez GI, Zarea AA, Ge TJ, Withrow A, Ibrahim SA, Toomajian V, Gambhir SS, Paulmurugan R, Contag CH.

Mol Cancer Ther. 2019 Aug 26. pii: molcanther.0299.2019. doi: 10.1158/1535-7163.MCT-19-0299. [Epub ahead of print]

PMID:
31451563
16.

Reply to "Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management".

Startin CM, Hamburg S, Hithersay R, Al-Janabi T, Mok KY, Hardy J, Strydom A.

Alzheimers Dement. 2019 Sep;15(9):1238-1239. doi: 10.1016/j.jalz.2019.05.003. Epub 2019 Aug 23. No abstract available.

PMID:
31451423
17.

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.

Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R; PRACTICAL study team.

Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23.

PMID:
31451207
18.

Endorsement and Constructive Criticism of an Innovative Online Reflexive Self-Talk Intervention.

Latinjak AT, Hernando-Gimeno C, Lorido-Méndez L, Hardy J.

Front Psychol. 2019 Aug 6;10:1819. doi: 10.3389/fpsyg.2019.01819. eCollection 2019.

19.

Culture-independent and dependent evaluation of the equine paranasal sinus microbiota in health and disease.

Beste KJ, Lawhon SD, Chamoun-Emanuelli AM, Duff AH, Coleman MC, Griffin CE, Hardy J, Whitfield-Cargile CM.

Equine Vet J. 2019 Aug 22. doi: 10.1111/evj.13168. [Epub ahead of print]

PMID:
31437314
20.

A Nanopore Approach for Analysis of Caspase-7 Activity in Cell Lysates.

Pham B, Eron SJ, Hill ME, Li X, Fahie MA, Hardy JA, Chen M.

Biophys J. 2019 Sep 3;117(5):844-855. doi: 10.1016/j.bpj.2019.07.045. Epub 2019 Aug 2.

PMID:
31427065
21.

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujić-Čomić H, Frosch MP, Thonberg H, Maier W, Roshchupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT Jr, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Uitterlinden AGA, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O'Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, Quinn JF, Sacchinelli E, Raj A, Spalletta G, Raskind M, Caltagirone C, Bossù P, Orfei MD, Reisberg B, Clarke R, Reitz C, Smith AD, Ringman JM, Warden D, Roberson ED, Wilcock G, Rogaeva E, Bruni AC, Rosen HJ, Gallo M, Rosenberg RN, Ben-Shlomo Y, Sager MA, Mecocci P, Saykin AJ, Pastor P, Cuccaro ML, Vance JM, Schneider JA, Schneider LS, Slifer S, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tang M, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Saba Y; Alzheimer Disease Genetics Consortium (ADGC); European Alzheimer’s Disease Initiative (EADI); Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE); Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES), Pilotto A, Bullido MJ, Peters O, Crane PK, Bennett D, Bosco P, Coto E, Boccardi V, De Jager PL, Lleo A, Warner N, Lopez OL, Ingelsson M, Deloukas P, Cruchaga C, Graff C, Gwilliam R, Fornage M, Goate AM, Sanchez-Juan P, Kehoe PG, Amin N, Ertekin-Taner N, Berr C, Debette S, Love S, Launer LJ, Younkin SG, Dartigues JF, Corcoran C, Ikram MA, Dickson DW, Nicolas G, Campion D, Tschanz J, Schmidt H, Hakonarson H, Clarimon J, Munger R, Schmidt R, Farrer LA, Van Broeckhoven C, O'Donovan MC, DeStefano AL, Jones L, Haines JL, Deleuze JF, Owen MJ, Gudnason V, Mayeux R, Escott-Price V, Psaty BM, Ramirez A, Wang LS, Ruiz A, van Duijn CM, Holmans PA, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Lambert JC, Pericak-Vance MA.

Nat Genet. 2019 Sep;51(9):1423-1424. doi: 10.1038/s41588-019-0495-7.

PMID:
31417202
22.

Patient Blood Management is not about blood transfusion: it is about patients' outcomes.

Frietsch T, Shander A, Faraoni D, Hardy JF.

Blood Transfus. 2019 Sep;17(5):331-333. doi: 10.2450/2019.0126-19. Epub 2019 Jul 18. No abstract available.

23.

Risk of hospitalization for common neonatal morbidities in preterm and term infants: assessing the impact of one or more major congenital anomalies.

Hardy JR, Pimenta JM, Pokras S, Sehdev H, Laurent SS, Black L, Coyle M.

J Perinatol. 2019 Aug 8. doi: 10.1038/s41372-019-0460-4. [Epub ahead of print]

PMID:
31395956
24.

Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications.

Hill M, Twigg M, Sheridan EA, Hardy JG, Elborn JS, Taggart CC, Scott CJ, Migaud ME.

Pharmaceutics. 2019 Aug 2;11(8). pii: E379. doi: 10.3390/pharmaceutics11080379.

25.

Quality use of medicines: Oral corticosteroids in advanced cancer.

Pinkerton E, Good P, Kindl K, Richard R, Fischer A, Hardy JR.

Palliat Med. 2019 Aug 5:269216319866647. doi: 10.1177/0269216319866647. [Epub ahead of print] No abstract available.

PMID:
31378135
26.

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia.

Bonham LW, Steele NZR, Karch CM, Broce I, Geier EG, Wen NL, Momeni P, Hardy J, Miller ZA, Gorno-Tempini ML, Hess CP, Lewis P, Miller BL, Seeley WW, Manzoni C, Desikan RS, Baranzini SE, Ferrari R, Yokoyama JS; International FTD-Genomics Consortium (IFGC).

Sci Rep. 2019 Jul 26;9(1):10854. doi: 10.1038/s41598-019-46415-1.

27.

Non-coding variability at the APOE locus contributes to the Alzheimer's risk.

Zhou X, Chen Y, Mok KY, Kwok TCY, Mok VCT, Guo Q, Ip FC, Chen Y, Mullapudi N; Alzheimer’s Disease Neuroimaging Initiative, Giusti-Rodríguez P, Sullivan PF, Hardy J, Fu AKY, Li Y, Ip NY.

Nat Commun. 2019 Jul 25;10(1):3310. doi: 10.1038/s41467-019-10945-z.

28.

Genes, pathways and risk prediction in Alzheimer's disease.

Hardy J, Escott-Price V.

Hum Mol Genet. 2019 Jul 23. pii: ddz163. doi: 10.1093/hmg/ddz163. [Epub ahead of print]

PMID:
31332445
29.

Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.

Tan MMX, Malek N, Lawton MA, Hubbard L, Pittman AM, Joseph T, Hehir J, Swallow DMA, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Bresner C, Foltynie T, Hardy J, Wood N, Ben-Shlomo Y, Grosset DG, Williams NM, Morris HR.

Brain. 2019 Sep 1;142(9):2828-2844. doi: 10.1093/brain/awz191.

30.

Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.

Baker E, Sims R, Leonenko G, Frizzati A, Harwood JC, Grozeva D; GERAD/PERADES; CHARGE; ADGC; EADI; IGAP consortia, Morgan K, Passmore P, Holmes C, Powell J, Brayne C, Gill M, Mead S, Bossù P, Spalletta G, Goate AM, Cruchaga C, Maier W, Heun R, Jessen F, Peters O, Dichgans M, FröLich L, Ramirez A, Jones L, Hardy J, Ivanov D, Hill M, Holmans P, Allen ND, Morgan BP, Seshadri S, Schellenberg GD, Amouyel P, Williams J, Escott-Price V.

PLoS One. 2019 Jul 8;14(7):e0218111. doi: 10.1371/journal.pone.0218111. eCollection 2019.

31.

Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer's Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers.

Huentelman M, De Both M, Jepsen W, Piras IS, Talboom JS, Willeman M, Reiman EM, Hardy J, Myers AJ.

Sci Rep. 2019 Jul 3;9(1):9640. doi: 10.1038/s41598-019-45896-4.

32.

Call for coordinated antimicrobial approach at veterinary diagnostic laboratories.

Allerton F, Fishwick J, Paterson S, Weller R, Battersby I, Doyle R, Gould D, Caddy S, Dunning M, Featherstone HJ, Hardy J, Kent A, Pedro B, Smith K, Swinbourne F, Harris J, Heinrich C, Lau-Gillard P, Loeffler A, Maddinson R, Mason C, Ramsey I, Ridyard A, Robin L, Scudder C, Seth M, Tappin S, Singleton D, Smith H, Southerden P, Warland J, Whitehead M, Williams J.

Vet Rec. 2019 Jun 29;184(26):805-806. doi: 10.1136/vr.l4383. No abstract available.

PMID:
31249126
33.

Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT.

Hill M, Cunningham RN, Hathout RM, Johnston C, Hardy JG, Migaud ME.

J Funct Biomater. 2019 Jun 13;10(2). pii: E26. doi: 10.3390/jfb10020026.

34.

Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition.

Leonenko G, Shoai M, Bellou E, Sims R, Williams J, Hardy J, Escott-Price V; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2019 Sep;86(3):427-435. doi: 10.1002/ana.25530. Epub 2019 Jul 1.

35.

Correction: Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment.

Chaudhury S, Brookes KJ, Patel T, Fallows A, Guetta-Baranes T, Turton JC, Guerreiro R, Bras J, Hardy J, Francis PT, Croucher R, Holmes C, Morgan K.

Transl Psychiatry. 2019 Jun 11;9(1):167. doi: 10.1038/s41398-019-0503-9.

36.

To me, to you: How you say things matters for endurance performance.

Hardy J, Thomas AV, Blanchfield AW.

J Sports Sci. 2019 Sep;37(18):2122-2130. doi: 10.1080/02640414.2019.1622240. Epub 2019 May 28.

PMID:
31135272
37.

Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment.

Chaudhury S, Brookes KJ, Patel T, Fallows A, Guetta-Baranes T, Turton JC, Guerreiro R, Bras J, Hardy J, Francis PT, Croucher R, Holmes C, Morgan K, Thomas AJ.

Transl Psychiatry. 2019 May 24;9(1):154. doi: 10.1038/s41398-019-0485-7. Erratum in: Transl Psychiatry. 2019 Jun 11;9(1):167.

38.

Harms From Haloperidol for Symptom Management in Palliative Care-a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies.

Matsuoka H, Agar M, Vandersman Z, Good P, Fazekas B, Brown L, Hardy J, Weil J, Currow DC.

J Pain Symptom Manage. 2019 Sep;58(3):e6-e8. doi: 10.1016/j.jpainsymman.2019.05.004. Epub 2019 May 20. No abstract available.

PMID:
31121249
39.

L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression.

Malek N, Kanavou S, Lawton MA, Pitz V, Grosset KA, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Williams NM, Wood N, Morris HR, Grosset DG; PRoBaND clinical consortium.

Parkinsonism Relat Disord. 2019 Aug;65:55-61. doi: 10.1016/j.parkreldis.2019.05.022. Epub 2019 May 14.

PMID:
31105012
40.

Chemoproteomics Using Nucleotide Acyl Phosphates Reveals an ATP Binding Site at the Dimer Interface of Procaspase-6.

Okerberg ES, Dagbay KB, Green JL, Soni I, Aban A, Nomanbhoy TK, Savinov SN, Hardy JA, Kozarich JW.

Biochemistry. 2019 May 24. doi: 10.1021/acs.biochem.9b00290. [Epub ahead of print]

PMID:
31095371
41.

Rheumatology Care Using Telemedicine.

Rezaian MM, Brent LH, Roshani S, Ziaee M, Sobhani F, Dorbeigi A, Fatehi Z, Hardy J, Haghi YR, Maghsoudi T, Beinaghi F.

Telemed J E Health. 2019 May 14. doi: 10.1089/tmj.2018.0256. [Epub ahead of print]

PMID:
31084537
42.

Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability.

Reynolds RH, Botía J, Nalls MA; International Parkinson’s Disease Genomics Consortium (IPDGC); System Genomics of Parkinson’s Disease (SGPD), Hardy J, Gagliano Taliun SA, Ryten M.

NPJ Parkinsons Dis. 2019 Apr 17;5:6. doi: 10.1038/s41531-019-0076-6. eCollection 2019.

43.

Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study.

van de Goor RMGE, Hardy JCA, van Hooren MRA, Kremer B, Kross KW.

Head Neck. 2019 Sep;41(9):2983-2990. doi: 10.1002/hed.25787. Epub 2019 Apr 23.

44.

Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7).

King MT, Agar M, Currow DC, Hardy J, Fazekas B, McCaffrey N.

Support Care Cancer. 2019 Apr 16. doi: 10.1007/s00520-019-04754-9. [Epub ahead of print]

PMID:
30993452
45.

Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.

Arber C, Toombs J, Lovejoy C, Ryan NS, Paterson RW, Willumsen N, Gkanatsiou E, Portelius E, Blennow K, Heslegrave A, Schott JM, Hardy J, Lashley T, Fox NC, Zetterberg H, Wray S.

Mol Psychiatry. 2019 Apr 12. doi: 10.1038/s41380-019-0410-8. [Epub ahead of print]

PMID:
30980041
46.

Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.

Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrøm L, Simón-Sánchez J, Schulte C, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Lesage S, Corvol JC, Brice A, van Hilten JJ, Marinus J; 23andMe Research Team, Eerola-Rautio J, Tienari P, Majamaa K, Toft M, Grosset DG, Gasser T, Heutink P, Shulman JM, Wood N, Hardy J, Morris HR, Hinds DA, Gratten J, Visscher PM, Gan-Or Z, Nalls MA, Singleton AB; International Parkinson's Disease Genomics Consortium (IPDGC).

Mov Disord. 2019 Jun;34(6):866-875. doi: 10.1002/mds.27659. Epub 2019 Apr 7.

PMID:
30957308
47.

Heritability and genetic variance of dementia with Lewy bodies.

Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A; International Parkinson's Disease Genomics Consortium, Stone DJ, Bras J.

Neurobiol Dis. 2019 Jul;127:492-501. doi: 10.1016/j.nbd.2019.04.004. Epub 2019 Apr 3.

PMID:
30953760
48.

Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy.

Guelfi S, Botia JA, Thom M, Ramasamy A, Perona M, Stanyer L, Martinian L, Trabzuni D, Smith C, Walker R, Ryten M, Reimers M, Weale ME, Hardy J, Matarin M.

Brain. 2019 Jun 1;142(6):1616-1630. doi: 10.1093/brain/awz074.

PMID:
30932156
49.

Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues.

Ferrari R, Manzoni C, Hardy J.

Neurobiol Aging. 2019 Jun;78:98-110. doi: 10.1016/j.neurobiolaging.2019.02.006. Epub 2019 Feb 14. Review.

PMID:
30925302
50.

Polygenic risk and hazard scores for Alzheimer's disease prediction.

Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, Fox NC, Williams J; GERAD consortium, Hardy J, Escott-Price V.

Ann Clin Transl Neurol. 2019 Feb 18;6(3):456-465. doi: 10.1002/acn3.716. eCollection 2019 Mar.

Supplemental Content

Support Center